Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Absci Corporation - SIC # 2830 -
Ticker
Exchange
SIC #
Website
Latest Ticker
ABSI
Nasdaq
2830
www.absci.com
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Absci Corporation
Absci Highlights AI Antibody Platform, Teases ABS-201 Hair-Loss Data and 2026 Milestones at Needham Conference
- Apr 16th, 2026 1:03 pm
Absci to Participate in the 25th Annual Needham Virtual Healthcare Conference
- Apr 8th, 2026 6:00 am
Here's Why We're Watching Absci's (NASDAQ:ABSI) Cash Burn Situation
- Mar 26th, 2026 5:04 am
Absci (ABSI) Q4 2025 Earnings Call Transcript
- Mar 25th, 2026 7:32 am
Absci Corporation Q4 2025 Earnings Call Summary
- Mar 25th, 2026 6:30 am
Absci Corp (ABSI) Q4 2025 Earnings Call Highlights: Strategic Advances and Financial Resilience
- Mar 24th, 2026 9:01 pm
Absci Q4 Earnings Call Highlights
- Mar 24th, 2026 4:45 pm
Absci Corporation (ABSI) Reports Q4 Loss, Misses Revenue Estimates
- Mar 24th, 2026 3:25 pm
Absci Reports Business Updates and Fourth Quarter and Full Year 2025 Financial and Operating Results
- Mar 24th, 2026 2:05 pm
Absci Launches ABS-201 Endometriosis Advisory Board with Leading Experts from Yale, UCSF, Duke, and the Mayo Clinic
- Mar 24th, 2026 6:00 am
InflaRx N.V. (IFRX) Reports Q4 Loss, Lags Revenue Estimates
- Mar 19th, 2026 6:45 am
Absci Highlights AI Antibody Platform, ABS-201 Hair-Loss Trial Milestones at Leerink Conference
- Mar 9th, 2026 4:36 pm
Absci Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
- Mar 6th, 2026 2:05 pm
Absci Strengthens Clinical Leadership with Appointment of Ransi Somaratne, M.D., FACC, MBA as Chief Medical Officer
- Mar 3rd, 2026 6:00 am
Absci Conference: Agentic AI Push and ABS-201 Hair-Loss Program Take Center Stage
- Mar 2nd, 2026 10:15 am
Absci to Report Business Updates and Fourth Quarter and Full Year 2025 Financial and Operating Results on March 24, 2026
- Feb 24th, 2026 6:00 am
Absci to Participate in Upcoming Investor Conferences
- Feb 17th, 2026 6:00 am
Absci Corporation's (NASDAQ:ABSI) recent 12% pullback adds to one-year year losses, institutional owners may take drastic measures
- Jan 21st, 2026 3:51 am
Absci Unveils Origin-1 AI Model, Teases 2025 Hair-Loss Data and Q4 Endometriosis Trial Launch
- Jan 14th, 2026 7:07 pm
Analysts Cut Absci (ABSI) Target, Spotlight New Alopecia Therapy in Early Trials
- Jan 14th, 2026 12:13 pm
Scroll